Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics

The current global COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in a public health crisis with more than 168 million cases reported globally and more than 4.5 million deaths at the time of writing. In addition to the direct impact of the disea...

Descripción completa

Detalles Bibliográficos
Autores principales: House, Robert V., Broge, Thomas A., Suscovich, Todd J., Snow, Doris M., Tomic, Milan T., Nonet, Genevieve, Bajwa, Kamaljit, Zhu, Guangyu, Martinez, Zachary, Hackett, Kyal, Earnhart, Christopher G., Dorsey, Nicole M., Hopkins, Svetlana A., Natour, Dalia S., Davis, Heather D., Anderson, Michael S., Gainey, Melicia R., Cobb, Ronald R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165815/
https://www.ncbi.nlm.nih.gov/pubmed/35657812
http://dx.doi.org/10.1371/journal.pone.0267796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165815/
https://www.ncbi.nlm.nih.gov/pubmed/35657812
http://dx.doi.org/10.1371/journal.pone.0267796

Ejemplares similares